How Enteric Coating Changes Aspirin's Absorption
Enteric coating on aspirin tablets uses pH-sensitive polymers like cellulose acetate phthalate that resist stomach acid (pH 1-3) but dissolve in the small intestine's higher pH (5-7). This delays release of acetylsalicylic acid (ASA), shifting absorption from the stomach to the duodenum and jejunum.[1]
Uncoated aspirin dissolves rapidly in the stomach, achieving peak plasma levels in 20-40 minutes. Enteric-coated versions take 3-4 hours for peak levels, with total bioavailability similar (around 70-90%) but slower onset.[2][3]
Why Use Enteric Coating on Aspirin?
It protects the stomach lining from direct ASA contact, reducing irritation and ulceration risk—key for daily low-dose therapy (e.g., 81 mg for cardioprotection). Studies show 50-80% lower gastric bleeding incidence versus uncoated forms.[4]
Does It Reduce Overall Effectiveness?
No, for antiplatelet effects. Salicylate levels build steadily for sustained inhibition of COX-1. But for acute pain relief, uncoated aspirin works faster, so enteric isn't ideal there.[5]
Absorption in Different Stomach Conditions
In low-acid states (e.g., antacids, hypochlorhydria), uncoated aspirin absorbs normally, but enteric coating may fail to dissolve properly, cutting bioavailability by 20-50%.[6] Food delays both but more so for enteric (up to 6 hours peak).[3]
Buffered vs. Enteric-Coated Aspirin
Buffered adds antacids to neutralize acid but still releases in stomach (faster onset than enteric). Enteric avoids stomach entirely for better GI tolerance, though some buffered products mimic enteric effects.[7]
Clinical Data on Absorption Profiles
| Formulation | Tmax (hours) | Cmax (µg/mL, 650mg dose) | Bioavailability (%) |
|-------------|--------------|---------------------------|---------------------|
| Uncoated | 0.5-1 | 15-20 | 80-100 |
| Enteric | 3-5 | 10-15 | 70-90 |[2][8]
Real-world variance comes from coating thickness, patient pH, and transit time.
[1] PubMed: Enteric coatings overview
[2] FDA Aspirin Label
[3] J Clin Pharmacol study
[4] Lancet meta-analysis on GI risk
[5] Circulation review
[6] Pharm Res on pH effects
[7] USP monograph comparison
[8] Clin Pharmacokinet data